[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367945-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367945-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nanotechnology-driven-treatment-strategies-for-breast-cancer-review-recent-advances-and-innovations","Nanotechnology-Driven Treatment Strategies for Breast Cancer - Review - Recent Advances and Innovations","","Breast cancer is among the most prevalent cancers in females globally and has the highest mortality rate. Pharmacologic resistance poses a significant barrier to developing effective therapies. Advances in cancer nanotechnology are reshaping delivery approaches through smart polymers, lipids, and inorganic materials, enabling nano-pharmaceutical formulations that improve efficacy and chemotherapy durability. Nanotechnology-based systems offer theranostic capabilities, stronger encapsulation, reduced degradation, and minimized adverse effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nanotechnology-driven-treatment-strategies-for-breast-cancer-review-recent-advances-and-innovations/367945/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nanotechnology-driven-treatment-strategies-for-breast-cancer-review-recent-advances-and-innovations/367945.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What challenge does pharmacologic resistance create in breast cancer treatment?","Question",{"text":63,"@type":64},"Pharmacologic resistance is a significant challenge because it reduces the effectiveness of available therapies, complicating researchers’ efforts to develop durable treatment strategies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do nanotechnology-based delivery systems help in breast cancer therapy?",{"text":68,"@type":64},"They support theranostic applications, enhance drug encapsulation, decrease degradation, and aim to reduce adverse effects while improving chemotherapy efficacy and durability.",{"name":70,"@type":61,"acceptedAnswer":71},"What topics does the review cover regarding breast cancer and nanomedicines?",{"text":72,"@type":64},"It discusses breast cancer and its stages, risk factors and pathogenesis, diagnosis and treatment, novel nanocarriers, clinical usage, and also patents and promising clinical trial results, including nanotoxicity, ethical concerns, and regulations.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367945,1790195478,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":97,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Tech Science Press  \nDoi:10.32604/or.2025.066624  \nREVIEW  \nNanotechnology-Driven Treatment Strategies for Breast Cancer: Recent Advances and Innovations  \nNeha Raina1, Radha Rani2, Mahika Kanojia2, Avril Mathias3, Keshav Raj Paudel4, *, Ashish Garg5, Hardeep Singh Tuli6, A. T. M. Mijanur Rahman7, Vetriselvan Subramaniyan8 and Madhu Gupta2, *  \n1 Centre for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105, India  \n2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, 110017, India  \n3 Department of Pharmaceutics, Nitte College of Pharmaceutical Sciences, Bangalore, 560064, India  \n4 Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW 2050, Australia  \n5 Department of Pharmaceutics, Guru Ramdas Khalsa Institute of Science and Technology, Jabalpur, 483001, India  \n6 Centre of Excellence in Computational Research and Drug Discovery, Department of Bio-Sciences and Technology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), Mullana, Ambala, India 7 Bio-nanotechnology and Nanomedicine Lab., Dept. of Applied Nutrition and Food Technology, Islamic University, Kushtia, 7003, Bangladesh  \n8 Division of Pharmacology, Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, 47500, Malaysia  \n*[Corresponding Authors: Keshav Raj Paudel. Email: keshavraj.paudel@uts.edu.au](Corresponding Authors: Keshav Raj Paudel. Email: keshavraj.paudel@uts.edu.au); [Madhu Gupta. Email: madhugupta98@gmail.com](Madhu Gupta. Email: madhugupta98@gmail.com)  \nReceived: 13 April 2025; Accepted: 07 August 2025; Published: 26 September 2025  \nABSTRACT: Breast cancer is among the most prevalent cancers in females globally and has the highest mortality rate. The emergence of pharmacologic resistance in breast cancer is a significant challenge for researchers in the pursuit of effective treatment. Investigations in cancer nanotechnology have been transformed by the advancement of smart polymers, lipids, and inorganic materials. Research is now being conducted in the field of innovative nano-pharmaceutical formulations aimed at enhancing the efficacy and durability of chemotherapy. Nanotechnologybased delivery systems are beneficial for combating breast cancer due to theranostic applications, augmented drug encapsulation, decreased degradation, and minimal adverse effects. This review discusses breast cancer and its stages, various risk factors, and pathogenesis, in addition to diagnosis and treatment. Novel nanocarriers are included with the most recent findings in this area and the potential use of these nanocarriers in cancer therapy that centers on their clinical usage for improved treatment. Patents and promising clinical trial results are also explained in detail, with nanotoxicity, ethical concerns, and regulations. This study underscores the importance of treatment strategies using nanotechnology, highlighting the advancing paradigm of breast cancer care. This article examines the prospects, obstacles, and future trajectories of nanomedicines.  \nKEYWORDS: Breast cancer; diagnosis; therapeutic strategy; nanotechnology; clinical trials  \n1 Introduction  \nCancer represents a proliferative disorder with a multifaceted character and is considered the leading cause of significant demises worldwide [1]. Now, it is regarded as the most common barrier to life, shortening  \nCopyright © 2025 The Authors. Published by Tech Science Press.  \nThis work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nthe life span worldwide [2] . Mutational changes in the genetic material will result in uncontrolled growth of ","cbCaipXYpRpBOFyV","https://ap.wps.com/l/cbCaipXYpRpBOFyV","pdf",47614742,45,"English","# Abstract\n# Keywords\n## Introduction\n## Breast cancer overview and stages\n## Diagnosis and treatment strategies\n## Nanocarriers and clinical prospects\n## Patents, clinical trials, and regulations","[{\"question\":\"What challenge does pharmacologic resistance create in breast cancer treatment?\",\"answer\":\"Pharmacologic resistance is a significant challenge because it reduces the effectiveness of available therapies, complicating researchers’ efforts to develop durable treatment strategies.\"},{\"question\":\"How do nanotechnology-based delivery systems help in breast cancer therapy?\",\"answer\":\"They support theranostic applications, enhance drug encapsulation, decrease degradation, and aim to reduce adverse effects while improving chemotherapy efficacy and durability.\"},{\"question\":\"What topics does the review cover regarding breast cancer and nanomedicines?\",\"answer\":\"It discusses breast cancer and its stages, risk factors and pathogenesis, diagnosis and treatment, novel nanocarriers, clinical usage, and also patents and promising clinical trial results, including nanotoxicity, ethical concerns, and regulations.\"}]","Nanotechnology-Driven Treatment Strategies for Breast Cancer - Review - Recent Advances and Innovations | PDF",1790173475,113,[147,151,155,159,163],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dbafd88f0c2806857043cbd3d5bad0d.webp",983,1271,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d905ba75dd99d88649267a1342d3b04c.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f51cb33161bd41d6ea76f22442f3b360.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c27ace388365bec2f2cf33f194cc16f.webp",980,1267,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cd654236c63ca9e1ba5cb3d842dd1a2.webp",979,1266]